Trexquant Investment’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Trexquant Investment’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-35,422	Closed	-$961K	–	1223
2019 Q2	$961K	Buy	35,422 +19,934	+129%	+$625K	0.09%	327
2019 Q1	$537K	Buy	+15,488	New	+$447K	0.04%	568
2018 Q4	–	Sell	-33,440	Closed	-$891K	–	1427
2018 Q3	$891K	Buy	+33,440	New	+$1.09M	0.07%	387
2018 Q2	–	Sell	-14,756	Closed	-$482K	–	1376
2018 Q1	$482K	Buy	+14,756	New	+$648K	0.03%	651
2017 Q4	–	Sell	-7,325	Closed	-$396K	–	1340
2017 Q3	$396K	Sell	7,325 -1,975	-21%	-$116K	0.1%	356
2017 Q2	$522K	Sell	9,300 -18,321	-66%	-$734K	0.14%	229
2017 Q1	$1.08M	Buy	+27,621	New	+$880K	0.14%	220
2016 Q4	–	Sell	-30,682	Closed	-$697K	–	1212
2016 Q3	$697K	Sell	30,682 -20,493	-40%	-$481K	0.16%	211
2016 Q2	$1.21M	Buy	51,175 +28,412	+125%	+$701K	0.16%	184
2016 Q1	$464K	Sell	22,763 -38,537	-63%	-$1.22M	0.05%	574
2015 Q4	$3.15M	Buy	+61,300	New	+$2.97M	0.28%	67
2015 Q3	–	Sell	-17,900	Closed	-$815K	–	1361
2015 Q2	$815K	Sell	17,900 -8,400	-32%	-$338K	0.09%	415
2015 Q1	$998K	Buy	+26,300	New	+$903K	0.1%	368

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Trexquant Investment's PTLA Position: Q3 2019 in Review

Trexquant Investment sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2019, closing a stake of 35,422 shares — an estimated $961K sold.

Trexquant Investment first reported a position in PTLA in Q1 2015 and held it in 13 quarters. The position peaked at $3.15M in Q4 2015. 212 funds tracked by Wall St. Rank hold PTLA as of Q3 2019.

Trexquant Investment reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
Trexquant Investment sold 35,422 Portola Pharmaceuticals, Inc. shares in Q3 2019, an estimated $961K.
Trexquant Investment first reported a position in Portola Pharmaceuticals, Inc. in Q1 2015 and held it in 13 quarters.
Trexquant Investment's Portola Pharmaceuticals, Inc. position peaked at $3.15M in Q4 2015.
212 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2019.

Based on Trexquant Investment's 13F filing for Q3 2019, filed 8 Nov 2019.